Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Duality Biotherapeutics, Inc. ( (HK:9606) ).
Duality Biotherapeutics, Inc., a company incorporated in the Cayman Islands, has announced its inclusion as a constituent of the Hang Seng Composite Index and as part of the eligible stock list for the Southbound Trading Link of the Shanghai-Hong Kong Stock Connect. This development signifies strong market recognition of the company’s performance and value, potentially expanding its investor base and increasing trading liquidity by allowing mainland Chinese investors to invest directly in its shares.
The most recent analyst rating on (HK:9606) stock is a Buy with a HK$367.06 price target. To see the full list of analyst forecasts on Duality Biotherapeutics, Inc. stock, see the HK:9606 Stock Forecast page.
More about Duality Biotherapeutics, Inc.
Average Trading Volume: 271,225
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$31.97B
For detailed information about 9606 stock, go to TipRanks’ Stock Analysis page.